Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Assessment of preoperative axillary nodal disease burden: breast MRI in locally advanced breast cancer before, during and after neoadjuvant endocrine therapy

Fig. 2

Matric Scatter plots illustrate the correlation between the difference of maximal diameters between MRI and pathological assessments. MRI scans at baseline, between regimens and posttreatment. The correlation between posttreatment MRI lymph node size and pathology was positive, moderate and higher (r = 0.6, P ≤ .001) compared to the correlation between MRI at baseline and between regimens (r = 0.431, P ≤ .05; r = 0.425, P ≤ .05, respectively). Among all the three MRI examinations, the correlation coefficient was highest and very high positive between MRI at baseline and between regimens (r = 0.97, P ≤ .001). BR: between regimens, NET: neoadjuvant endocrine therapy; Posttreat: posttreatment; r: the Pearson correlation coefficient

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us